Literature DB >> 8977118

Characterization of a human gene related to genes encoding somatostatin receptors.

L F Kolakowski1, B P Jung, T Nguyen, M P Johnson, K R Lynch, R Cheng, H H Heng, S R George, B F O'Dowd.   

Abstract

We report the identification of a gene, named SLC-1(1), encoding a novel G protein-coupled receptor (GPCR). A customized search procedure of a database of expressed sequence tags (dbEST) retrieved a human cDNA sequence that partially encoded a GPCR. A genomic DNA fragment identical to the cDNA was obtained and used to screen a library to isolate the full-length coding region of the gene. This gene was intronless in its open reading frame, and encoded a receptor of 402 amino acids, and shared -40% amino acid identity in the transmembrane (TM) regions to the five known human somatostatin receptors. Northern blot analysis revealed that SLC-1 is expressed in human brain regions, including the forebrain and hypothalamus. Expression in the rat was highest in brain, followed by heart, kidney, and ovary. Expression of SLC-1 in COS-7 cells failed to show specific binding to radiolabelled Tyr1-somatostatin-14, naloxone, bremazocine, 1,3-di(2-tolyl)-guanidine (DTG), or haloperidol. A repeat polymorphism of the form (CA)n was discovered in the 5'-untranslated region (UTR) of the gene and SLC-1 was mapped to chromosome 22, q13.3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977118     DOI: 10.1016/s0014-5793(96)01160-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

2.  Identification and characterization of a melanin-concentrating hormone receptor.

Authors:  S An; G Cutler; J J Zhao; S G Huang; H Tian; W Li; L Liang; M Rich; A Bakleh; J Du; J L Chen; K Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 3.  Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.

Authors:  Toshiharu Shimazaki; Takao Yoshimizu; Shigeyuki Chaki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  [125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor.

Authors:  V Audinot; C Lahaye; T Suply; P Beauverger; M Rodriguez; J P Galizzi; J L Fauchère; J A Boutin
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

5.  The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.

Authors:  E Helen Kemp; Elizabeth A Waterman; Brian E Hawes; Kim O'Neill; Raju V S R K Gottumukkala; David J Gawkrodger; Anthony P Weetman; Philip F Watson
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Phenotypic correlations in a patient with ring chromosome 22.

Authors:  Osman Demirhan; Erdal Tunç
Journal:  Indian J Hum Genet       Date:  2010-05

Review 7.  MCH receptors/gene structure-in vivo expression.

Authors:  Shinjae Chung; Yumiko Saito; Olivier Civelli
Journal:  Peptides       Date:  2009-08-06       Impact factor: 3.750

8.  Characterization of two melanin-concentrating hormone genes in zebrafish reveals evolutionary and physiological links with the mammalian MCH system.

Authors:  Jennifer R Berman; Gemini Skariah; Géraldine S Maro; Emmanuel Mignot; Philippe Mourrain
Journal:  J Comp Neurol       Date:  2009-12-10       Impact factor: 3.215

9.  Melanin-concentrating hormone as a mediator of intestinal inflammation.

Authors:  Efi Kokkotou; Alan C Moss; Daniel Torres; Iordanes Karagiannides; Adam Cheifetz; Sumei Liu; Michael O'Brien; Eleftheria Maratos-Flier; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

Review 10.  The role of melanin-concentrating hormone in energy homeostasis and mood disorders.

Authors:  Ildiko Antal-Zimanyi; Xavier Khawaja
Journal:  J Mol Neurosci       Date:  2009-05-06       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.